Search

Your search keyword '"Harrison, Rebecca A."' showing total 1,021 results

Search Constraints

Start Over You searched for: Author "Harrison, Rebecca A." Remove constraint Author: "Harrison, Rebecca A." Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
1,021 results on '"Harrison, Rebecca A."'

Search Results

4. Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.

7. Cycle Threshold Values as Indication of Increasing SARS-CoV-2 New Variants, England, 2020-2022

11. Merleau-Ponty and Standpoint Theory

13. Preface

16. The Infant KIdney Dialysis and Utrafiltration (I-KID) Study: A Stepped-Wedge Cluster-Randomized Study in Infants, Comparing Peritoneal Dialysis, Continuous Venovenous Hemofiltration, and Newcastle Infant Dialysis Ultrafiltration System, a Novel Infant Hemodialysis Device

17. A genetic and pharmacogenetic study of clozapine in schizophrenia

19. The need for more inclusive deliberation on ethics and governance in agricultural and food biotechnology

21. Patient and health-care provider experience of a person-centred, multidisciplinary, psychosocial support and harm reduction programme for patients with harmful use of alcohol and drug-resistant tuberculosis in Minsk, Belarus

22. Neurologic Toxicities of Immunotherapy

23. Significant Locus and Metabolic Genetic Correlations Revealed in Genome-Wide Association Study of Anorexia Nervosa

25. ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma

38. Table S4 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

39. INNV-35. IMPLEMENTATION OF A NATIONAL ADOLESCENT AND YOUNG ADULT MOLECULAR TUMOR BOARD: REPORT FROM THE CANADIAN AYA NEURO-ONCOLOGY NETWORK

40. Supplementary Figures 1-15 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

41. Supplementary Data S2 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

42. Data from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

48. An investigation of spatial and temporal pesticide dynamics at the catchment scale

49. Portland's maritime history

50. Characterization of patients with brain metastases referred to palliative care.

Catalog

Books, media, physical & digital resources